Antiviral Metal Complexes
1997
Antiviral Metal Complexes
publication
Evidence: moderate
Author Information
Author(s): Erik De Clercq
Primary Institution: Rega Institute for Medical Research, Katholieke Universiteit Leuven
Hypothesis
How do metal-binding compounds interfere with HIV's viral glycoproteins and cell receptors?
Conclusion
Metal-binding compounds can inhibit HIV replication by interfering with the virus's ability to adsorb and fuse with host cells.
Supporting Evidence
- Polyanionic substances can inhibit HIV-induced cytopathicity at very low concentrations.
- Bicyclam derivatives have shown high potency against HIV with minimal toxicity to host cells.
- The G-octet forming oligonucleotide T30177 exhibits long-lasting anti-HIV activity even after removal from cell cultures.
- Resistance mutations in HIV have been linked to the use of polyanionic substances and bicyclams.
Takeaway
Some special metal compounds can stop HIV from getting into our cells and making us sick.
Methodology
The study investigates the effects of various metal-binding compounds on HIV's ability to infect cells.
Limitations
Little is known about the clinical potential of these compounds, and resistance to some compounds has been observed.
Want to read the original?
Access the complete publication on the publisher's website